Skip to main content
Clinical Trials/JPRN-UMIN000033845
JPRN-UMIN000033845CompletedPhase 1

Continuous measurement of blood pressure and blood glucose by a wearable vital sign system using FBG censer and verification of its mechanism. - Continuous measure of blood pressure and glucose by FBG censer.

Shinshu University0 sites120 target enrollmentStarted: August 25, 2018Last updated:
Conditions

Trial Snapshot

Phase
Phase 1
Status
Completed
Enrollment
120

Study Overview

Brief Summary

FBG sensor signal supported the diameter of radial artery conjugation, and it became clear that this accorded with the pressure of the fluid, and the shape of the pulsation distortion signal changed by age and was an estimate in blood vessel age or arteriosclerotic possibility from a wave pattern shape. Blood pressure calculation was possible as a parameter with the size of the vertical axis direction of the pulsation distortion wave pattern.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
20years-old to 90years-old (—)
Sex
All

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Subjects having chronic atrial fibrillation, severe arrhythmia, peripheral circulatory failure such as Raynaud's disease, severe deformed nail, and are judged as inappropriate by chief researcher.

Investigators

Similar Trials